These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 17089135

  • 1. Involvement of hypocretin neurons in multiple system atrophy.
    Benarroch EE, Schmeichel AM, Sandroni P, Low PA, Parisi JE.
    Acta Neuropathol; 2007 Jan; 113(1):75-80. PubMed ID: 17089135
    [Abstract] [Full Text] [Related]

  • 2. Differential involvement of hypothalamic vasopressin neurons in multiple system atrophy.
    Benarroch EE, Schmeichel AM, Sandroni P, Low PA, Parisi JE.
    Brain; 2006 Oct; 129(Pt 10):2688-96. PubMed ID: 16670175
    [Abstract] [Full Text] [Related]

  • 3. Depletion of putative chemosensitive respiratory neurons in the ventral medullary surface in multiple system atrophy.
    Benarroch EE, Schmeichel AM, Low PA, Parisi JE.
    Brain; 2007 Feb; 130(Pt 2):469-75. PubMed ID: 17235127
    [Abstract] [Full Text] [Related]

  • 4. Hypocretin/orexin peptide signaling in the ascending arousal system: elevation of intracellular calcium in the mouse dorsal raphe and laterodorsal tegmentum.
    Kohlmeier KA, Inoue T, Leonard CS.
    J Neurophysiol; 2004 Jul; 92(1):221-35. PubMed ID: 14999052
    [Abstract] [Full Text] [Related]

  • 5. Depletion of medullary serotonergic neurons in patients with multiple system atrophy who succumbed to sudden death.
    Tada M, Kakita A, Toyoshima Y, Onodera O, Ozawa T, Morita T, Nishizawa M, Takahashi H.
    Brain; 2009 Jul; 132(Pt 7):1810-9. PubMed ID: 19429902
    [Abstract] [Full Text] [Related]

  • 6. Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy.
    Schmeichel AM, Buchhalter LC, Low PA, Parisi JE, Boeve BW, Sandroni P, Benarroch EE.
    Neurology; 2008 Jan 29; 70(5):368-73. PubMed ID: 18227417
    [Abstract] [Full Text] [Related]

  • 7. Rostral raphe involvement in Lewy body dementia and multiple system atrophy.
    Benarroch EE, Schmeichel AM, Sandroni P, Parisi JE, Low PA.
    Acta Neuropathol; 2007 Sep 29; 114(3):213-20. PubMed ID: 17639427
    [Abstract] [Full Text] [Related]

  • 8. Relationship between CSF hypocretin levels and hypocretin neuronal loss.
    Gerashchenko D, Murillo-Rodriguez E, Lin L, Xu M, Hallett L, Nishino S, Mignot E, Shiromani PJ.
    Exp Neurol; 2003 Dec 29; 184(2):1010-6. PubMed ID: 14769395
    [Abstract] [Full Text] [Related]

  • 9. CSF hypocretin-1 levels are normal in multiple-system atrophy.
    Abdo WF, Bloem BR, Kremer HP, Lammers GJ, Verbeek MM, Overeem S.
    Parkinsonism Relat Disord; 2008 Dec 29; 14(4):342-4. PubMed ID: 17977056
    [Abstract] [Full Text] [Related]

  • 10. Involvement of medullary serotonergic groups in multiple system atrophy.
    Benarroch EE, Schmeichel AM, Low PA, Parisi JE.
    Ann Neurol; 2004 Mar 29; 55(3):418-22. PubMed ID: 14991820
    [Abstract] [Full Text] [Related]

  • 11. Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons.
    Borgland SL, Storm E, Bonci A.
    Eur J Neurosci; 2008 Oct 29; 28(8):1545-56. PubMed ID: 18793323
    [Abstract] [Full Text] [Related]

  • 12. Depletion of ventromedullary NK-1 receptor-immunoreactive neurons in multiple system atrophy.
    Benarroch EE, Schmeichel AM, Low PA, Parisi JE.
    Brain; 2003 Oct 29; 126(Pt 10):2183-90. PubMed ID: 12902309
    [Abstract] [Full Text] [Related]

  • 13. Excitatory action of hypocretin/orexin on neurons of the central medial amygdala.
    Bisetti A, Cvetkovic V, Serafin M, Bayer L, Machard D, Jones BE, Mühlethaler M.
    Neuroscience; 2006 Nov 03; 142(4):999-1004. PubMed ID: 16996221
    [Abstract] [Full Text] [Related]

  • 14. Involvement of vagal autonomic nuclei in multiple system atrophy and Lewy body disease.
    Benarroch EE, Schmeichel AM, Sandroni P, Low PA, Parisi JE.
    Neurology; 2006 Feb 14; 66(3):378-83. PubMed ID: 16476936
    [Abstract] [Full Text] [Related]

  • 15. [Loss of catecholaminergic neuron in the hypothalamus of multiple system atrophy].
    Tsai A, Maehara K, Iizuka R.
    Rinsho Shinkeigaku; 1992 Feb 14; 32(2):125-30. PubMed ID: 1351801
    [Abstract] [Full Text] [Related]

  • 16. Hypocretin (orexin) loss in Parkinson's disease.
    Fronczek R, Overeem S, Lee SY, Hegeman IM, van Pelt J, van Duinen SG, Lammers GJ, Swaab DF.
    Brain; 2007 Jun 14; 130(Pt 6):1577-85. PubMed ID: 17470494
    [Abstract] [Full Text] [Related]

  • 17. alpha-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy.
    Sone M, Yoshida M, Hashizume Y, Hishikawa N, Sobue G.
    Acta Neuropathol; 2005 Jul 14; 110(1):19-26. PubMed ID: 15895299
    [Abstract] [Full Text] [Related]

  • 18. Depletion of catecholaminergic neurons of the rostral ventrolateral medulla in multiple systems atrophy with autonomic failure.
    Benarroch EE, Smithson IL, Low PA, Parisi JE.
    Ann Neurol; 1998 Feb 14; 43(2):156-63. PubMed ID: 9485056
    [Abstract] [Full Text] [Related]

  • 19. Stereological analysis of the hypothalamic hypocretin/orexin neurons in an animal model of depression.
    Allard JS, Tizabi Y, Shaffery JP, Trouth CO, Manaye K.
    Neuropeptides; 2004 Oct 14; 38(5):311-5. PubMed ID: 15464197
    [Abstract] [Full Text] [Related]

  • 20. Non-sleep effects of hypocretin/orexin.
    Samson WK, Taylor MM, Ferguson AV.
    Sleep Med Rev; 2005 Aug 14; 9(4):243-52. PubMed ID: 16036174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.